{"id":"https://openalex.org/W2019068993","doi":"https://doi.org/10.1016/s0040-4039(01)01338-7","title":"A synthesis of the HIV-protease inhibitor nelfinavir from d-tartaric acid","display_name":"A synthesis of the HIV-protease inhibitor nelfinavir from d-tartaric acid","publication_year":2001,"publication_date":"2001-09-01","ids":{"openalex":"https://openalex.org/W2019068993","doi":"https://doi.org/10.1016/s0040-4039(01)01338-7","mag":"2019068993"},"language":"en","primary_location":{"id":"doi:10.1016/s0040-4039(01)01338-7","doi":"https://doi.org/10.1016/s0040-4039(01)01338-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0040-4039(01)01338-7","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110857676","display_name":"Kim F. Albizati","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kim F Albizati","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045971034","display_name":"Srinivasan Babu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Srinivasan Babu","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060601204","display_name":"Angela G. Birchler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela Birchler","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026019837","display_name":"Juliette K. Busse","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Juliette K Busse","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007095090","display_name":"Michelle Fugett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michelle Fugett","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073641531","display_name":"Alan W. Grubbs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Grubbs","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001561962","display_name":"Aubrey A. Haddach","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aubrey Haddach","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012386656","display_name":"Miguel Pagan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miguel Pagan","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083370321","display_name":"Barbara C. M. Potts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Potts","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027186074","display_name":"Travis P. Remarchuk","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Travis Remarchuk","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110032090","display_name":"Dale L. Rieger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dale Rieger","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057638046","display_name":"Rick Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rick Rodriguez","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026820074","display_name":"Jim Shanley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jim Shanley","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002752850","display_name":"Robert J. Szendroi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Szendroi","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059328432","display_name":"Tony Tibbetts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tony Tibbetts","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015405472","display_name":"Kathleen Whitten","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kathleen Whitten","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036741917","display_name":"Bennett C. Borer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Bennett C Borer","raw_affiliation_strings":["Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Agouron Pharmaceuticals, Inc., Chemical R&D, Pfizer Global R&D, La Jolla, 3565 General Atomics Ct., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036741917"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":3610,"currency":"USD","value_usd":3610},"apc_paid":null,"fwci":0.7233,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.71137644,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"42","issue":"37","first_page":"6481","last_page":"6485"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.5098000168800354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10013","display_name":"Asymmetric Synthesis and Catalysis","score":0.20919999480247498,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nelfinavir","display_name":"nelfinavir","score":1.0},{"id":"https://openalex.org/keywords/hiv-protease-inhibitors","display_name":"HIV protease inhibitors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/d-tartaric-acid","display_name":"D-tartaric acid","score":0.8949999809265137},{"id":"https://openalex.org/keywords/cyclic-sulfates","display_name":"cyclic sulfates","score":0.6610000133514404},{"id":"https://openalex.org/keywords/nitrogen-nucleophiles","display_name":"nitrogen nucleophiles","score":0.7789999842643738},{"id":"https://openalex.org/keywords/total-synthesis","display_name":"total synthesis","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.9517616629600525},{"id":"https://openalex.org/C2781160516","wikidata":"https://www.wikidata.org/wiki/Q423366","display_name":"Nelfinavir","level":5,"score":0.9435491561889648},{"id":"https://openalex.org/C2780048820","wikidata":"https://www.wikidata.org/wiki/Q194322","display_name":"Tartaric acid","level":3,"score":0.8120759725570679},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.5313487648963928},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.4930884540081024},{"id":"https://openalex.org/C178907741","wikidata":"https://www.wikidata.org/wiki/Q745930","display_name":"Nucleophile","level":3,"score":0.436781108379364},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.42882871627807617},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.40061724185943604},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3875402510166168},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.24658775329589844},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2044256329536438},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.13743948936462402},{"id":"https://openalex.org/C161790260","wikidata":"https://www.wikidata.org/wiki/Q82264","display_name":"Catalysis","level":2,"score":0.07288861274719238},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0},{"id":"https://openalex.org/C2779032678","wikidata":"https://www.wikidata.org/wiki/Q159683","display_name":"Citric acid","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s0040-4039(01)01338-7","doi":"https://doi.org/10.1016/s0040-4039(01)01338-7","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0040-4039(01)01338-7","pdf_url":null,"source":{"id":"https://openalex.org/S133942674","display_name":"Tetrahedron Letters","issn_l":"0040-4039","issn":["0040-4039","1873-3581"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","jufo-1","ki-jl-1","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tetrahedron Letters","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.4000000059604645}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W1971154885","https://openalex.org/W2027095884","https://openalex.org/W2059286247","https://openalex.org/W2117965525","https://openalex.org/W2949532533","https://openalex.org/W2951479609","https://openalex.org/W4244600542"],"related_works":["https://openalex.org/W2914926765","https://openalex.org/W2952776691","https://openalex.org/W2018097831","https://openalex.org/W2075310721","https://openalex.org/W2172906829","https://openalex.org/W2949532533","https://openalex.org/W1977046410","https://openalex.org/W2009135952","https://openalex.org/W2952400221","https://openalex.org/W2044215445"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2015,"cited_by_count":2}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2016-06-24T00:00:00"}